• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Amazon, Starbucks, Home Depot in the Hot Seat As Boycotts Heat Up

July 2, 2025

Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July

July 2, 2025

10 Budgeting Rules That Are Quietly Hurting Middle-Class Families

July 2, 2025
Facebook Twitter Instagram
Trending
  • Amazon, Starbucks, Home Depot in the Hot Seat As Boycotts Heat Up
  • Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July
  • 10 Budgeting Rules That Are Quietly Hurting Middle-Class Families
  • How One Founder Is Rethinking Supplements With David Beckham
  • Why Your Finance Team Needs an AI Strategy, Now
  • AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000
  • He Went From $471K in Debt to Teaching Others How to Succeed
  • Summer Financial Checklist
Wednesday, July 2
Facebook Twitter Instagram
FintechoPro
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
FintechoPro
Home » Eli Lilly hits record high after earnings, Mounjaro hype. Here’s what the pros are saying
News

Eli Lilly hits record high after earnings, Mounjaro hype. Here’s what the pros are saying

News RoomBy News RoomAugust 9, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

Market Movers rounded up the best reactions from investors and analysts on Eli Lilly . The experts, including Jim Cramer , discussed the drugmaker after it reported second-quarter revenue and earnings Tuesday that beat Wall Street estimates. The company also raised its full-year guidance as quarterly profit soared 85% from the same period last year. Shares of Eli Lilly hit an all-time high during intraday trading, perhaps also getting a boost from a Novo Nordisk trial. The study found Novo Nordisk’s obesity drug Wegovy, which shares some similarities with Lilly’s Mounjaro, cut the risk of heart disease in participants by 20%. Eli Lilly’s stock finished the day about 14.9% higher. LLY is currently held in Cramer’s Charitable Trust portfolio.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

RSS Feed Generator, Create RSS feeds from URL

News November 22, 2024

X CEO Linda Yaccarino addresses Musk’s ‘go f—- yourself’ comment to advertisers

News November 30, 2023

67-year-old who left the U.S. for Mexico: I’m happily retired—but I ‘really regret’ doing these 3 things in my 20s

News November 30, 2023

U.S. GDP grew at a 5.2% rate in the third quarter, even stronger than first indicated

News November 29, 2023

Americans are ‘doom spending’ — here’s why that’s a problem

News November 29, 2023

Jim Cramer’s top 10 things to watch in the stock market Tuesday

News November 28, 2023
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Check Your Budget: 15 Cities and States Are Hiking Minimum Wage in July

July 2, 20250 Views

10 Budgeting Rules That Are Quietly Hurting Middle-Class Families

July 2, 20250 Views

How One Founder Is Rethinking Supplements With David Beckham

July 1, 20250 Views

Why Your Finance Team Needs an AI Strategy, Now

July 1, 20250 Views
Don't Miss

AI Startup TML From Ex-OpenAI Exec Mira Murati Pays $500,000

By News RoomJuly 1, 2025

The $10 billion AI startup Thinking Machines Lab (TML), which was founded by former OpenAI…

He Went From $471K in Debt to Teaching Others How to Succeed

July 1, 2025

Summer Financial Checklist

July 1, 2025

3 Gently Used Cars You Can Still Buy for Under $20,000

July 1, 2025
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 FintechoPro. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.